Divi's Laboratories · NSE: DIVISLAB · BSE: 532488
Q3 FY23 results · Oct–Dec 2022
Divi's Laboratories reported revenue from operations of ₹1,707.68 crore (down 31.5% from Q3 FY22) and net profit of ₹306.80 crore (down 66.0% from Q3 FY22) for Q3 FY23 (Oct–Dec 2022), on a consolidated basis.
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,707.68 | 2,493.24 | −31.5% | 1,854.54 | −7.9% |
| Other income | 114.25 | 16.62 | +587.4% | 80.08 | +42.7% |
| Total income | 1,821.93 | 2,509.86 | −27.4% | 1,934.62 | −5.8% |
| Profit before tax | 435.63 | 1,033.66 | −57.9% | 615.22 | −29.2% |
| Net profit for the period | 306.80 | 902.24 | −66.0% | 493.60 | −37.8% |
| EPS, basic (₹) | 11.56 | 33.99 | −66.0% | 18.60 | −37.8% |
| Net margin (%) | 18.0 | 36.2 | 26.6 |
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,689.83 | 2,466.77 | −31.5% | 1,823.38 | −7.3% |
| Other income | 116.34 | 16.62 | +600.0% | 79.25 | +46.8% |
| Total income | 1,806.17 | 2,483.39 | −27.3% | 1,902.63 | −5.1% |
| Profit before tax | 439.11 | 1,036.62 | −57.6% | 602.90 | −27.2% |
| Net profit for the period | 310.90 | 907.22 | −65.7% | 486.85 | −36.1% |
| EPS, basic (₹) | 11.71 | 34.17 | −65.7% | 18.34 | −36.2% |
| Net margin (%) | 18.4 | 36.8 | 26.7 |
Consolidated
- Filed with BSE
- 03 Feb 2023, 18:06 IST
- Board meeting
- 03 Feb 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 03 Feb 2023, 18:06 IST
- Board meeting
- 03 Feb 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE